Vuno, Canon to target AI diagnostic market in Japan

The S.Korean startup’s local partner M3AI signed a MOU with Canon Medical Systems to cooperate for sales

Vuno, Canon to target AI diagnostic market in Japan
Jeong Min Nam 1
2024-04-30 11:17:51 peux@hankyung.com
Artificial intelligence

South Korea's medical device startup Vuno announced on Monday that its Japanese partner M3AI signed a memorandum of understanding (MOU) with Canon Medical Systems to cooperate for sales in Japan. 

M3AI, specializing in medical AI marketing, holds the Japanese rights to Vuno's Vuno Med LungCT AI, a chest CT reading aid solution.

The MOU allows M3AI to reach over 30% of Japanese hospitals that use picture archiving and communication systems (PACS).

Both companies will collaborate in joint marketing using their AI sales networks in Japan. 

In March, the company said that Japan's Ministry of Health, Labour and Welfare announced revisions to the health insurance fee system, which will add more hospitals as customers.

To bolster the adoption of AI in healthcare, Japan has decided to broaden the range of medical institutions that can claim reimbursement for medical AI services.

This revision, slated to take effect in June, will make Vuno's products eligible for insurance coverage in Japan.

Write to Jeong Min Nam at peux@hankyung.com

Vuno's brain imaging AI medical device secures FDA certification

Vuno's brain imaging AI medical device secures FDA certification

South Korea's medical device startup Vuno announced on Tuesday that its AI-powered brain quantification device Vuno Med-DeepBrain has received the 510(k) certification from the US Food and Drug Administration (FDA).The 510(k) certification process, an FDA approval system, confirms the safety a

Vuno's fundus-reading AI obtains medical device certification in Thailand

Vuno's fundus-reading AI obtains medical device certification in Thailand

Vuno's fundus-reading AI solution South Korea's medical device startup company Vuno announced on Thursday that its fundus reading artificial intelligence (AI) solution Vuno Med-Fundus AI has acquired medical device certification from the Thai Food and Drug Administration (TFDA).Earlier, the Kor

Vuno's AI-powered fundus reading solution approved for sale in Taiwan

Vuno's AI-powered fundus reading solution approved for sale in Taiwan

Vuno Med-Fundus AI, a solution that provides findings for retinal disease diagnosis (Courtesy of Vuno) Vuno Inc., a South Korean artificial intelligence-powered medical solutions provider, said on Tuesday that Vuno Med-Fundus AI has received marketing license approval from the Taiwan Food and D

(* comment hide *}